Miguel Elias
Aguado Barrera
Maastricht University Medical Centre
Maastricht, HolandaPublicacións en colaboración con investigadores/as de Maastricht University Medical Centre (11)
2023
-
Comparison of prone and supine positioning for breast cancer radiotherapy using REQUITE data: dosimetry, acute and two years physician and patient-reported outcomes
Acta Oncologica, Vol. 62, Núm. 9, pp. 1036-1044
2022
-
Development and Optimization of a Machine-Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE Cohort
Advances in Radiation Oncology, Vol. 7, Núm. 3
-
No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity
International Journal of Radiation Oncology Biology Physics, Vol. 114, Núm. 3, pp. 494-501
-
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)
Lung Cancer, Vol. 166, pp. 228-241
-
Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort
eBioMedicine, Vol. 84
-
Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancer
Radiotherapy and Oncology, Vol. 168, pp. 75-82
2021
-
Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity
Radiotherapy and Oncology, Vol. 159, pp. 241-248
2020
2019
-
Publisher Correction: Shared heritability and functional enrichment across six solid cancers (Nature Communications, (2019), 10, 1, (431), 10.1038/s41467-018-08054-4)
Nature Communications
-
REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer
Radiotherapy and Oncology, Vol. 138, pp. 59-67
-
Shared heritability and functional enrichment across six solid cancers
Nature Communications, Vol. 10, Núm. 1